Website News and Research

RSS

HCCMIS redesigns its website to emphasize new social media offerings

With the increasing popularity of social networking tools like Facebook and Twitter, expectations on both sides of the business/consumer relationship have changed.

19 Nov 2009

Nigerian Contact Centre Market to reach $114.45 million by 2015

Despite industry challenges, the rising consumer demand from developing industry sectors will drive exponential growth in the Nigerian contact centre market. The outsourced contact centre segment, email and SMS services and the health and medical organisation (HMO) and the public sectors are expected to become key areas of market growth from 2009 to 2015.

19 Nov 2009

HTHH and Soles4Souls team up to provide athletic shoes for Tennessee children

Hope Through Healing Hands (HTHH), a nonprofit founded by former Senator Bill Frist, M.D., has announced a partnership with Nashville-based Soles4Souls to benefit over 100,000 Tennessee children who are in need of a good pair of athletic shoes.

19 Nov 2009

Results from Phase IIa clinical trial evaluating VT-111 reported by Viron Therapeutics

Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.

19 Nov 2009

Horizon Health International announces its two new websites

HORIZON HEALTH INTERNATIONAL CORP. (PINK SHEETS:HZHI) (The Company) is pleased to announce its two new websites.

19 Nov 2009

ScienceWorksForUS launched by the representatives of public and private research universities

Representatives of the nation's leading public and private research universities, joined by Speaker Nancy Pelosi and other Members of Congress, today announced the launch of ScienceWorksForUS, an initiative that will highlight the scientific research and related activities that have been made possible by the American Recovery and Reinvestment Act of 2009 (ARRA), also known as the stimulus.

18 Nov 2009

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

American Biotech Labs, LLC (ABL), developer of a new class of products based on the company's patented nano-catalytic SilverSol Technology(R), today announced that the company has obtained clearance by the U.S. Food and Drug Administration (FDA) to market its ASAP Antibacterial Silver Wound Dressing Gel as a prescription 510(k) medical device throughout the United States. Clifton Mining Company is a major shareholder in American Biotech Labs.

17 Nov 2009

New website for senior care from A Softer Place

A Softer Place, LLC has announced the completion of Stage I of www.asofterplace.com. Refreshingly easy to use, straightforward, and timely, this Dallas-based website is the ultimate in online local advertising. It brings together only the very best senior care facilities, professionals and service providers in the area, in one comprehensive and informative directory; a “go to” place, where those who need help can find it quickly and easily with “two clicks” of the mouse.

17 Nov 2009

Omega Healthcare Investors signs securities purchase agreement with CapitalSource

Omega Healthcare Investors, Inc. (NYSE: OHI) today announced that it has entered into a securities purchase agreement with CapitalSource Inc. and several of its affiliates to purchase entities owning 80 long term care facilities (“Facilities”) for approximately $565 million. The purchase price includes a purchase option (“Option”) to acquire entities owning an additional 63 Facilities for approximately $295 million.

17 Nov 2009

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it has filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code with the United States Bankruptcy Court for the District of Delaware to facilitate the sale of substantially all of its assets. deCODE is continuing to operate its business and manage its properties as a debtor-in-possession pursuant to Sections 1107 and 1108 of the Bankruptcy Code.

17 Nov 2009

Colorado receives “D” on Premature Birth Report Card for the second consecutive year

For the second consecutive year, Colorado received a “D” on the Premature Birth Report Card issued by the March of Dimes. However, the state did show improvement in two key areas that affect prematurity, including the rate of smoking for childbearing-age women.

17 Nov 2009

Remedent net sales decreases to $1.8 million in fiscal second quarter ended September 30, 2009

Remedent, Inc., an international company specializing in the research, development, and manufacturing of oral care and cosmetic dentistry products, reported results for the fiscal second quarter ended September 30, 2009 (in U.S. dollars).

17 Nov 2009

Cold weather can trigger Raynaud's disease

Cold weather triggers a painful and sometimes debilitating disorder for millions of Americans who suffer from Raynaud's disease (also known as Raynaud's syndrome or phenomenon). Raynaud's is an autoimmune disorder in which spasms in the blood vessels can interrupt blood flow to the fingers, toes, nose and ears. Exposure to cold triggers the spasms, typically causing the affected area to turn white, then blue, then bright red. Emotional stress can also cause an attack.

17 Nov 2009

Food allergies among children is increasing: Study

A newly published article provides further evidence that the prevalence of food allergies among children is increasing. The article, "Food Allergy Among Children in the United States" appears in the December issue of Pediatrics, a US medical journal.

17 Nov 2009

Dyadic International reports financial results for the third quarter of 2009

Dyadic International, Inc. today announced financial results for the third quarter ended September 30, 2009. The financial information contained in this press release should be read in conjunction with the financial statements and footnotes for the three and nine month periods ended September 30, 2009 as well as the financial statements, footnotes and independent auditors’ report for the year ended December 31, 2008 which have been posted on the Pink Sheets website at www.pinksheets.com and on Dyadic’s website at www.dyadic.com.

16 Nov 2009

Semafore Pharmaceuticals to present SF1126 Phase I data at the 51st ASH meeting

Researchers are scheduled to present Phase I data relating to Semafore Pharmaceuticals’ lead product candidate, SF1126, as a treatment for patients with relapsed and refractory myeloma during the 51st American Society of Hematology (ASH) Annual Meeting, December 5 - 8, 2009, at the Ernst N. Morial Convention Center in New Orleans, LA.

16 Nov 2009

Second Consumer Genetics Conference to be hosted at the Hynes Convention Center

The media spotlight will shine again on Boston from June 2nd – June 4th, 2010 as the Consumer Genetics Conference, (www.consumergeneticsconference.com), hosts its yearly conference at the Hynes Convention Center.

16 Nov 2009

Joslin Diabetes Center completes a major overhaul of its website

Joslin Diabetes Center, the world's preeminent diabetes research and clinical care organization, has completed a major overhaul of its website, to provide more easily accessible information and interactions for patients, researchers, healthcare professionals and the public.

16 Nov 2009

athenahealth receives U.S. Patent for its "Practice Management and Billing Automation System"

athenahealth, Inc., a leading provider of internet-based business services to physician practices, today announced that on November 10, 2009, the U.S. Patent and Trademark Office has issued athenahealth a patent entitled, ‘Practice Management and Billing Automation System’ (U.S. Patent No. 7,617,116) for its athenaNet® rules engine that is part of the Company’s revenue cycle management service, athenaCollectorSM.

13 Nov 2009

Merge Healthcare to sell up to 9,034,033 shares of common stock to institutional investors

Merge Healthcare announced today that it is offering to sell up to 9,034,033 shares of common stock in a registered direct offering to select institutional investors at a purchase price of $3.00 per share. Merge expects to enter into definitive agreements with respect to this offering later today.

13 Nov 2009

Website News and Research

HCCMIS redesigns its website to emphasize new social media offerings

Nigerian Contact Centre Market to reach $114.45 million by 2015

HTHH and Soles4Souls team up to provide athletic shoes for Tennessee children

Results from Phase IIa clinical trial evaluating VT-111 reported by Viron Therapeutics

Horizon Health International announces its two new websites

ScienceWorksForUS launched by the representatives of public and private research universities

American Biotech Labs' ASAP Antibacterial Silver Gel receives FDA 510(k) medical device clearance

New website for senior care from A Softer Place

Omega Healthcare Investors signs securities purchase agreement with CapitalSource

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

Colorado receives “D” on Premature Birth Report Card for the second consecutive year

Remedent net sales decreases to $1.8 million in fiscal second quarter ended September 30, 2009

Cold weather can trigger Raynaud's disease

Food allergies among children is increasing: Study

Dyadic International reports financial results for the third quarter of 2009

Semafore Pharmaceuticals to present SF1126 Phase I data at the 51st ASH meeting

Second Consumer Genetics Conference to be hosted at the Hynes Convention Center

Joslin Diabetes Center completes a major overhaul of its website

athenahealth receives U.S. Patent for its "Practice Management and Billing Automation System"

Merge Healthcare to sell up to 9,034,033 shares of common stock to institutional investors

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News